Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
HTG Molecular Diagnostics (DE:65HA)
STUTTGART:65HA
RESEARCH TOOLSreports
HTG Molecular Diagnostics (65HA) Financial Statements
0 Followers
HTG Molecular Diagnostics Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 1.25M | $ 1.49M | $ 1.18M | $ 2.88M | $ 2.52M |
| Gross Profit | $ 580.02K | $ 477.11K | $ 329.41K | $ 1.52M | $ 1.54M |
| EBIT | $ -4.31M | $ -5.64M | $ -6.25M | $ -4.92M | $ -4.22M |
| EBITDA | $ -4.18M | $ -5.48M | $ -6.06M | $ -4.77M | $ -4.03M |
| Net Income Common Stockholders | $ -4.52M | $ -5.89M | $ -6.50M | $ -5.19M | $ -4.49M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 6.53M | $ 14.10M | $ 21.56M | $ 21.94M | $ 25.42M |
| Total Assets | $ 13.61M | $ 22.21M | $ 28.46M | $ 30.46M | $ 34.51M |
| Total Debt | $ 6.05M | $ 9.07M | $ 9.47M | $ 11.71M | $ 11.95M |
| Net Debt | $ -477.09K | $ -5.03M | $ -12.09M | $ -10.23M | $ -13.47M |
| Total Liabilities | $ 12.40M | $ 16.64M | $ 17.20M | $ 20.06M | $ 19.62M |
| Stockholders Equity | $ 1.21M | $ 5.57M | $ 11.27M | $ 10.40M | $ 14.89M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -4.60M | $ -5.86M | $ -5.95M | $ -3.44M | $ -4.57M |
| Operating Cash Flow | $ -4.60M | $ -5.85M | $ -5.94M | $ -3.39M | $ -4.22M |
| Investing Cash Flow | $ 5.14M | $ -1.41M | $ 5.39M | $ 2.80M | $ 652.76K |
| Financing Cash Flow | $ -3.08M | $ -1.58M | $ 5.57M | $ -33.55K | $ 222.20K |
HTG Molecular Diagnostics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.